Related Experiment Video
Updated: Mar 6, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
The Heme Oxygenase System in Hematological Malignancies
Giovanni Li Volti1,2, Daniele Tibullo3, Luca Vanella4
11 Department of Biomedical and Biotechnological Sciences, University of Catania , Catania, Italy .
Altered redox balance in blood cancers fuels disease progression and chemoresistance. Inhibiting the heme oxygenase-1 (HO-1) pathway enhances chemotherapy efficacy and offers a promising therapeutic target.
Area of Science:
- Hematology
- Redox Biology
- Cancer Therapeutics
Background:
- Hematological malignancies are characterized by disrupted redox balance, promoting survival pathways and chemoresistance.
- The heme oxygenase-1 (HO-1) pathway plays a significant role in the progression and treatment resistance of these cancers.
Purpose of the Study:
- To review the role of HO-1 in hematological malignancies.
- To explore the potential of targeting HO-1 to improve chemotherapy outcomes.
Main Methods:
- Review of existing literature on HO-1 in hematological malignancies.
- Analysis of studies investigating HO-1 inhibition (siRNA, competitive inhibitors) in preclinical models.
Main Results:
- Inhibition of HO-1 expression or activity enhances chemotherapy efficacy in animal models.
- HO-1's non-canonical functions, including nuclear localization, are linked to genetic instability and chemoresistance in certain leukemias and myeloma.
Conclusions:
- The HO system presents a potential therapeutic target for overcoming chemoresistance in hematological malignancies.
- Targeting HO-1 could improve outcomes in combined therapeutic strategies and monitoring bone marrow transplants.
More Related Videos
Related Concept Videos
Oxygen Transport in the Blood
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

